apr. Kevin Van der borght
- Work address
- ORCID iD
- Bio (via ORCID)
- Kevin Van der borght is a Belgian pharmaceutical scientist and a doctoral fellow of the Flemish Research Foundation (FWO). As such, he is conducting Ph.D. research within the Drug Quality and Registration group at Ghent University, under the supervision of prof. Bart De Spiegeleer. Kevin holds an MSc degree in drug development from KU Leuven and wrote his thesis at Boehringer Ingelheim in Germany. He also attended UC Berkeley (Haas Business School) for a summer program. Next to his research position, Kevin is continuously educating himself in the fields of healthcare policy, economics, and management. Throughout his life as a young adult, Kevin has been involved in several youth and student organizations, including leadership roles such as president of a KLJ branch and vice-president of Farmaceutica vzw. He aims to continue this level of public engagement throughout his professional life as well.
- Journal Article
- open access
Bacterial quorum-sensing peptides as immune modulators present in systemic circulation(2023) BIOMOLECULES. 13(2).
A fit-for-purpose LC-MS/MS method for the analysis of selected Streptococcal quorum sensing peptides in human saliva
- Book Chapter
- open access
Liquid chromatography-mass spectrometry (LC-MS) analysis of bioactive peptides